Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
Go back to Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders| (AMEX: MBCOF) | Delayed: 0.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.12 | 52 Week High | $ | |||
| Open | $0.12 | 52 Week Low | $ | |||
| Day High | $0.12 | P/E | N/A | |||
| Day Low | $0.12 | EPS | $ | |||
| Volume | 623,687 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 325.01 +35.47 (12.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.54 | 52 Week High | $13.61 | |||
| Open | $305.47 | 52 Week Low | $7.40 | |||
| Day High | $328.53 | P/E | 507.83 | |||
| Day Low | $302.36 | EPS | $0.64 | |||
| Volume | 45,162,959 | |||||
